Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rongfang Tu

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Problems in Cancer|June 10, 2022
Non-bacterial cystitis secondary to pembrolizumab: A case report and review of the literatureXing He, Rongfang Tu, Saili Zeng, et al.
Scientific Reports|July 10, 2026
Internally validated machine learning models identify asthma and its phenotypes using multicenter real-world dataRongfang Tu, Sha Liu, Xiaowu Tan, et al.
Environment International|May 30, 2026
FOXA1 protects against PM2.5-induced chronic lung injury via MARCHF8-dependent mitophagy inhibitionXu Wu, Lingfeng Liu, Dafei Wei, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 9, 2022
Influences of Two FEV<sub>1</sub> Reference Equations (GLI-2012 and GIRH-2017) on Airflow Limitation Classification Among COPD PatientsDafei Wei, Qi Wang, Shasha Liu, et al.
Journal of Gastroenterology and Hepatology|January 15, 2026
ATF3 Mediates the Immunoregulatory Role of the Tim-3 Pathway in Primary Biliary CholangitisJiamin Xu, Haitao Ma, Wenxia Yang, et al.
Digestive Diseases and Sciences|July 25, 2025
Spontaneous Hepatic Artery Thrombosis with Hepatic Infarction: Successful Interventional ThrombolysisJiamin Xu, Chenrui Zhang, Jiajun Lv, et al.
Journal of Thoracic Disease|March 12, 2026
Efficacy and safety of anlotinib combined with etoposide and platinum-based regimens in the first-line treatment of extensive-stage small-cell lung cancer: a systematic review and meta-analysisYun Jiang, Wusheng Deng, Shaochu Zheng, et al.
Gut|April 29, 2025
Parecoxib sequential with imrecoxib for occurrence and remission of severe acute pancreatitis: a multicentre, double-blind, randomised, placebo-controlled trialLuming Huang, Zhe Feng, Wenjuan Yang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Problems in Cancer|June 10, 2022
Non-bacterial cystitis secondary to pembrolizumab: A case report and review of the literatureXing He, Rongfang Tu, Saili Zeng, et al.
Scientific Reports|July 10, 2026
Internally validated machine learning models identify asthma and its phenotypes using multicenter real-world dataRongfang Tu, Sha Liu, Xiaowu Tan, et al.
Environment International|May 30, 2026
FOXA1 protects against PM2.5-induced chronic lung injury via MARCHF8-dependent mitophagy inhibitionXu Wu, Lingfeng Liu, Dafei Wei, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 9, 2022
Influences of Two FEV<sub>1</sub> Reference Equations (GLI-2012 and GIRH-2017) on Airflow Limitation Classification Among COPD PatientsDafei Wei, Qi Wang, Shasha Liu, et al.
Journal of Gastroenterology and Hepatology|January 15, 2026
ATF3 Mediates the Immunoregulatory Role of the Tim-3 Pathway in Primary Biliary CholangitisJiamin Xu, Haitao Ma, Wenxia Yang, et al.
Digestive Diseases and Sciences|July 25, 2025
Spontaneous Hepatic Artery Thrombosis with Hepatic Infarction: Successful Interventional ThrombolysisJiamin Xu, Chenrui Zhang, Jiajun Lv, et al.
Journal of Thoracic Disease|March 12, 2026
Efficacy and safety of anlotinib combined with etoposide and platinum-based regimens in the first-line treatment of extensive-stage small-cell lung cancer: a systematic review and meta-analysisYun Jiang, Wusheng Deng, Shaochu Zheng, et al.
Gut|April 29, 2025
Parecoxib sequential with imrecoxib for occurrence and remission of severe acute pancreatitis: a multicentre, double-blind, randomised, placebo-controlled trialLuming Huang, Zhe Feng, Wenjuan Yang, et al.
Pageof 1